Assembly Bio Announces Upcoming Investor Events
February 19 2021 - 8:00AM
Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage
biotechnology company developing innovative therapeutics targeting
hepatitis B virus (HBV), today announced two upcoming investor
events:
- 2021 Key Objectives and
Anticipated Progress Conference Call and Webcast,
concurrent with Q4 and year end 2020 financial results at 5 p.m. ET
on Thursday, February 25, 2021
- SVB Leerink
10th Annual Global Healthcare
Conference. John McHutchison AO, MD, Chief Executive
Officer and President to participate in fireside chat at 1:40 p.m.
ET on Friday, February 26, 2021
Both live audio events will be available in the “News &
Events” section of Assembly Bio’s website. The archived webcasts
will be available on Assembly Bio’s website beginning approximately
two hours after the event and will be archived and available for
replay for at least 30 days after the event.
About Assembly BiosciencesAssembly Biosciences,
Inc. is a clinical-stage biotechnology company developing
innovative therapeutics targeting hepatitis B virus (HBV). The HBV
program is focused on advancing a new class of potent, oral core
inhibitors that have the potential to increase cure rates for
chronically infected patients. For more information,
visit assemblybio.com.
Investor ContactAssembly Biosciences,
Inc.Lauren GlaserSenior Vice President, Investor Relations and
Corporate Affairs(415)
521-3828lglaser@assemblybio.com
Media ContactSam Brown Inc.Audra Friis(917)
519-9577ASMBMedia@sambrown.com
Assembly Biosciences (NASDAQ:ASMB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Assembly Biosciences (NASDAQ:ASMB)
Historical Stock Chart
From Sep 2023 to Sep 2024